Nottingham, United Kingdom
PHARMASEAL is an innovative startup in the pharmaceutical industry, offering a Clinical Trial Management System (CTMS) called Engility. Founded in 2016 in the United Kingdom, the company's mission is to create smarter technologies and innovative products for the improvement of human health. Their flagship product, Engility CTMS, simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. It leverages advanced engineering, offering enterprise management with rapid deployment, an intuitive user interface, and interoperability with other eClinical applications to optimize trial governance and oversight.
The startup recently secured a £500.00K Equity Crowdfunding investment on 24 September 2020. This investment will support PHARMASEAL in further developing and enhancing its CTMS while expanding its reach within the biopharmaceutical, medical device, and Contract Research Organization (CRO) sectors. With a focus on unified trial governance and the backing of industry leaders, PHARMASEAL is well-positioned to make significant contributions to the advancement of clinical trials and, ultimately, human health.
